Evaluation of Paraoxonase, Arylesterase and Malondialdehyde Levels in Schizophrenia Patients Taking Typical, Atypical and Combined Antipsychotic Treatment

OBJECTIVE: Human serum paraoxonase (PON1) prevents lipids from peroxidation and functions as an antioxidant mechanism. Malonyldialdehyde (MDA) is the final product of lipid peroxidation and can be used as an indicator of oxidative stress. The aim of this study was to investigate PON1, MDA, and aryle...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Psychopharmacol Neurosci
Autors principals: Güneş, Mehmet, Camkurt, Mehmet Akif, Bulut, Mahmut, Demir, Süleyman, İbiloğlu, Aslıhan Okan, Kaya, Mehmet Cemal, Atlı, Abdullah, Kaplan, İbrahim, Sir, Aytekin
Format: Artigo
Idioma:Inglês
Publicat: Korean College of Neuropsychopharmacology 2016
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5083945/
https://ncbi.nlm.nih.gov/pubmed/27776386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2016.14.4.345
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars